Johnson & Johnson (JNJ) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
State of Incorp. NJ
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27,40024,09533,49226,66620,43519,687
Cash and cash equivalents21,85914,12714,48713,98517,30518,107
Short-term investments5,5419,96819,00512,6813,1301,580
Other undisclosed cash, cash equivalents, and short-term investments      
Receivables14,87316,16015,28313,57614,48114,098
Inventory, net of allowances, customer advances and progress billings11,18112,48310,3879,3449,0208,599
Inventory11,18112,48310,3879,3449,0208,599
Asset, held-for-sale, not part of disposal group     94950
Other undisclosed current assets412,5561,8171,6511,2442,699
Total current assets:53,49555,29460,97951,23745,27446,033
Noncurrent Assets
Property, plant and equipment19,89819,80318,96218,76617,65817,035
Intangible assets, net (including goodwill)70,73393,55681,63889,79581,28278,064
Goodwill36,55845,23135,24636,39333,63930,453
Intangible assets, net (excluding goodwill)34,17548,32546,39253,40247,64347,611
Deferred income tax assets9,2799,12310,2238,534 
Other noncurrent assets14,1539,60210,2166,5625,6954,182
Other undisclosed noncurrent assets     7,8197,640
Total noncurrent assets:114,063132,084121,039123,657112,454106,921
TOTAL ASSETS:167,558187,378182,018174,894157,728152,954
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities19,84423,15929,36528,34923,87919,054
Taxes payable1,1121,3922,266818
Employee-related liabilities3,5863,4843,3543,098
Accounts payable9,63211,70311,0559,5058,5447,537
Accrued liabilities10,21211,45613,61213,9689,7157,601
Debt3,50012,8003,8002,6001,2002,800
Other undisclosed current liabilities22,93819,84312,06111,54410,8859,376
Total current liabilities:46,28255,80245,22642,49335,96431,230
Noncurrent Liabilities
Long-term debt and lease obligation25,88126,88829,98532,63526,49427,684
Long-term debt, excluding current maturities25,88126,88829,98532,63526,49427,684
Liabilities, other than long-term debt26,62127,88432,78436,48835,79934,288
Accounts payable and accrued liabilities2,8814,3065,7136,5597,4448,242
Deferred tax liabilities, net5,9587,506
Deferred income tax liabilities3,1936,3747,4877,214 
Liability, pension and other postretirement and postemployment benefits 7,1496,7678,89810,77110,6639,951
Other liabilities13,39810,43710,68611,94411,7348,589
Other undisclosed noncurrent liabilities      
Total noncurrent liabilities:52,50254,77262,76969,12362,29361,972
Total liabilities:98,784110,574107,995111,61698,25793,202
Equity
Equity, attributable to parent68,77476,80474,02363,27859,47159,752
Common stock3,1203,1203,1203,1203,1203,120
Treasury stock, value(75,662)(41,694)(39,099)(38,490)(38,417)(34,362)
Accumulated other comprehensive loss(12,527)(12,967)(13,058)(15,242)(15,891)(15,222)
Retained earnings153,843128,345123,060113,890110,659106,216
Total equity:68,77476,80474,02363,27859,47159,752
TOTAL LIABILITIES AND EQUITY:167,558187,378182,018174,894157,728152,954

Income Statement (P&L) ($ in millions)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues85,15994,94393,77582,58482,05981,581
Cost of revenue
(Cost of Goods and Services Sold)
(26,553)(31,089)(29,855)(28,427)(27,556)(27,091)
Gross profit:58,60663,85463,92054,15754,50354,490
Operating expenses(22,001)(40,472)(40,525)(34,671)(34,689)(34,692)
Operating income:36,60523,38223,39519,48619,81419,798
Nonoperating expense(5,373)(1,381)(436)(2,788)(2,168)(794)
Investment income, nonoperating1,26149053111357611
Other nonoperating expense(6,634)(1,871)(489)(2,899)(2,525)(1,405)
Interest and debt expense(772)(276)(183)(201)(318)(1,005)
Income from continuing operations before equity method investments, income taxes:30,46021,72522,77616,49717,32817,999
Other undisclosed loss from continuing operations before income taxes(15,398)     
Income from continuing operations before income taxes:15,06221,72522,77616,49717,32817,999
Income tax expense(1,736)(3,784)(1,898)(1,783)(2,209)(2,702)
Income from continuing operations:13,32617,94120,87814,71415,11915,297
Income before gain (loss) on sale of properties:20,87814,71415,11915,297
Income from discontinued operations21,827     
Net income available to common stockholders, basic:35,15317,94120,87814,71415,11915,297
Interest on convertible debt     11
Net income available to common stockholders, diluted:35,15317,94120,87814,71415,12015,298

Comprehensive Income ($ in millions)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income:35,15317,94120,87814,71415,11915,297
Other comprehensive income (loss)(4,741)912,184649(669)(1,791)
Comprehensive income, net of tax, attributable to parent:30,41218,03223,06215,36314,45013,506

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: